Who
Adam H. Schechter
Director
Company insider
Files Form 4 as: Director, DaVita; President & CEO, Labcorp Holdings; EVP & Pres-Global Human Health, Merck & Company; President, Global Pharms, Merck Sharp & Dohme.
In numbers
- Trades disclosed
- 310
- Buys
- 0
- Sells
- 25
- Bought
- $0
- Sold
- $87.7M
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 15 Jan 2007
- Last trade
- 15 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Aug 2026filed 18 Aug 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —278 at $0.00 | filing |
| 15 Aug 2026filed 18 Aug 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —278 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M4,669 at $320.37 | filing |
| 11 Aug 2026filed 12 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M4,669 at $320.37 | filing |
| 15 May 2026filed 18 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 15 May 2026filed 18 May 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 11 May 2026filed 13 May 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M5,903 at $254.50 | filing |
| 11 May 2026filed 13 May 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M5,903 at $254.50 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —58,470 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $7.0M26,106 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —58,470 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $7.0M26,106 at $268.38 | filing |
| 15 Mar 2026filed 17 Mar 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —332 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | DVA DaVitaProviders & Facilities | SEC FORM 4 Code A | —332 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $2.4M8,705 at $279.96 | filing |
| 3 Mar 2026filed 5 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $2.4M8,705 at $279.96 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.5M5,273 at $284.38 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —3,656 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $441K1,521 at $289.89 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,656 at $0.00 | filing |
News
Labcorp Holdings Inc. (NYSE:LH) Shares to Pay Quarterly Dividend of $0.72LH · dailypolitical.com · 21 Oct 2026Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 MlnLH · finanzen.ch · 20 Oct 2026Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026
0 headlines in the last 90 days name Adam H. Schechter; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.